Kate Murphy
Marketing Communications Specialist, Weil Institute

Marketing Communications Specialist, Weil Institute. Email: mukately@med.umich.edu

Nurse viewing AHI interface displayed on a laptop computer monitor.
Research News
Fifth Eye’s AHI-PI Demonstrates Ability to Detect Patient Deterioration Prior to Rapid Response Team Events: New Study Published in PLOS Digital Health
Fifth Eye, Inc., a spin-off of the Max Harry Weil Institute for Critical Care Research and Innovation, announced the publication of a new study in the peer-reviewed journal, PLOS Digital Health, demonstrating the power of the company’s Analytic for Hemodynamic Instability-Predictive Indicator (AHI-PI) in predicting patient deterioration before a Rapid Response Team (RRT) event. An RRT event occurs when a dedicated team of healthcare professionals is mobilized to respond to a patient's critical deterioration. Detecting patient deterioration early is crucial, as it provides clinicians with more time to intervene, potentially preventing crises, improving patient outcomes, and reducing hospital costs.
Close-up of multiple IV fluid bags in an operating room
Research News
U-M & Michigan Medicine collaboration addresses IV fluid shortage in less than 24 hours
In a rapid response to the dire shortage of intravenous (IV) fluid bags currently affecting hospitals nationwide, investigators from the University of Michigan (U-M) Max Harry Weil Institute for Critical Care Research and Innovation and U-M Precision Health have developed a novel projection model to help U-M Health teams conserve critical medical supplies.
Illustration of the BioHelmet depicting clean air flowing in via the helmet's shroud and contaminated air flowing out through the attached HEPA filter and waist-mounted fan unit.
Research News
Weil Institute spin-off InspireRx awarded over $2 million for patient isolation system guarding against airborne infections
InspireRx, LLC., a spin-off company of the University of Michigan (U-M) Max Harry Weil Institute for Critical Care Research and Innovation, received over $2 million in Small Business Innovation Research (SBIR) grants to support further development of the AerosolVE BioHelmet, a compact negative pressure system for patients with highly contagious airborne respiratory infections such as COVID-19.
Members of the Weil Institute Data Science and Commercialization teams stand at their table display during Celebrate Invention 2023.
Research News
Weil Institute to be Featured at 2024 Celebrate Invention!
The Weil Institute will have a major presence at this year's Celebrate Invention event, hosted by U-M Innovation Partnerships. Dr. Kevin Ward, Executive Director of the Institute, will speak as the 2024 Distinguished University Innovator of the Year. Precision Trauma and RUA Diagnostics, two Weil Institute partners, will display a novel tourniquet and breath analysis technology, respectively.
weil institute
News Release
U-M Team receives NIH grant for collaborative research to speed ARDS diagnosis
Through a $4.17M NIH grant, a team of biomedical engineers, medical clinicians and data scientists from the Max Harry Weil Institute for Critical Care Research and Innovation is collaboratively researching ways to develop a portable, non-invasive breathalyzer-type device and corresponding algorithm to quickly and accurately diagnose acute respiratory distress syndrome (ARDS).